TERRIE MAILHOT: Open Payments
NPI 1689618688 · WARWICK, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,174 in 150 payments from 16 companies in 2025. Trend: 2023 $4,590 · 2024 $3,484 · 2025 $3,174
Food & beverage: $3,174
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $712 |
| Otsuka America Pharmaceutical, Inc. | 20 | $503 |
| Alkermes, Inc. | 14 | $437 |
| Vanda Pharmaceuticals Inc. | 17 | $368 |
| E.R. Squibb & Sons, L.L.C. | 12 | $261 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $212 |
| Lundbeck LLC | 22 | $199 |
| Axsome Therapeutics, Inc. | 2 | $140 |
| Supernus Pharmaceuticals, Inc. | 6 | $108 |
| Teva Pharmaceuticals USA, Inc. | 3 | $62 |
Products named: VRAYLAR, REXULTI, FANAPT, COBENFY, LYBALVI, CAPLYTA, ARISTADA, Auvelity.
Industry payments across RI — which companies pay providers there.
